Tech Company Financing Transactions
Altis Biosystems Funding Round
Altis Biosystems, based in Chapel Hill, secured $3.1 million in funding from Atlanta Technology Angels, Central Texas Angel Network and Hatteras Venture Partners.
Transaction Overview
Company Name
Announced On
8/13/2020
Transaction Type
Venture Equity
Amount
$3,100,000
Round
Seed
Investors
Proceeds Purpose
This new funding as we accelerate the development and deployment of additional biologically accurate and comprehensive intestinal models with our pharma and biotech partners.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1289 Fordham BLVD. A234
Chapel Hill, NC 27514
USA
Chapel Hill, NC 27514
USA
Phone
Website
Email Address
Overview
Altis Biosystems was founded to address the biopharmaceutical industry's intense need for more accurate drug screening methods, using in vitro platforms, which can more closely replicate human biology. The inadequacies of current drug development methods, prior to human testing, have left the industry with an unacceptable 88% failure rate in clinical trials and $151B spent every year on research and development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Biron
Chief Scientific Officer
Scott Magness
President
Christopher Sims
Browse more venture capital transactions:
Prev: 8/13/2020: Gong venture capital transaction
Next: 8/13/2020: Trala venture capital transaction
Share this article
News on VC Transactions
We document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs